D P Lapenson

1.9k total citations · 1 hit paper
19 papers, 1.7k citations indexed

About

D P Lapenson is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, D P Lapenson has authored 19 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 11 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Molecular Biology. Recurrent topics in D P Lapenson's work include Pharmacogenetics and Drug Metabolism (14 papers), Hormonal and reproductive studies (8 papers) and Hormonal Regulation and Hypertension (5 papers). D P Lapenson is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Hormonal and reproductive studies (8 papers) and Hormonal Regulation and Hypertension (5 papers). D P Lapenson collaborates with scholars based in United States, Germany and United Kingdom. D P Lapenson's co-authors include David J. Waxman, Harry V. Gelboin, C Attisano, Frank J. Gonzalez, F. Peter Guengerich, Ken Korzekwa, Toshifumi Aoyama, Toshifumi Aoyama, Rachel F. Tyndale and W. Kalow and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Gastroenterology.

In The Last Decade

D P Lapenson

19 papers receiving 1.6k citations

Hit Papers

Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gen... 1989 2026 2001 2013 1989 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D P Lapenson United States 14 1.2k 606 470 440 210 19 1.7k
Miki Shimada Japan 28 961 0.8× 616 1.0× 441 0.9× 703 1.6× 176 0.8× 83 2.0k
Joyce L. Barwick United States 15 1.5k 1.2× 904 1.5× 642 1.4× 555 1.3× 541 2.6× 15 2.1k
David T. Molowa United States 15 1.1k 0.9× 782 1.3× 221 0.5× 417 0.9× 105 0.5× 16 1.7k
Thomas A. Kocarek United States 29 1.1k 0.9× 704 1.2× 437 0.9× 776 1.8× 408 1.9× 78 2.1k
Marie‐José Vilarem France 20 1.5k 1.2× 888 1.5× 686 1.5× 615 1.4× 503 2.4× 31 2.5k
Lydiane Pichard‐Garcia France 18 845 0.7× 519 0.9× 301 0.6× 348 0.8× 209 1.0× 27 1.8k
Lionel Drocourt France 8 910 0.7× 548 0.9× 379 0.8× 293 0.7× 319 1.5× 9 1.4k
Hans Postlind Sweden 13 805 0.7× 457 0.8× 393 0.8× 393 0.9× 296 1.4× 19 1.4k
Stephanie Faucette United States 14 984 0.8× 571 0.9× 244 0.5× 322 0.7× 186 0.9× 26 1.6k
Joanna M. Little United States 21 661 0.5× 415 0.7× 117 0.2× 658 1.5× 130 0.6× 36 1.5k

Countries citing papers authored by D P Lapenson

Since Specialization
Citations

This map shows the geographic impact of D P Lapenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D P Lapenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D P Lapenson more than expected).

Fields of papers citing papers by D P Lapenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D P Lapenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D P Lapenson. The network helps show where D P Lapenson may publish in the future.

Co-authorship network of co-authors of D P Lapenson

This figure shows the co-authorship network connecting the top 25 collaborators of D P Lapenson. A scholar is included among the top collaborators of D P Lapenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D P Lapenson. D P Lapenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Shapiro, B, Nisar A. Pampori, D P Lapenson, & David J. Waxman. (1994). Growth Hormone-Dependent and -Independent Sexually Dimorphic Regulation of Phenobarbital-Induced Hepatic Cytochrome P450 2B1 and -2B2. Archives of Biochemistry and Biophysics. 312(1). 234–239. 32 indexed citations
2.
Prough, Russell A., et al.. (1994). Induction of microsomal and peroxisomal enzymes by dehydroepiandrosterone and its reduced metabolite in rats.. PubMed. 54(11). 2878–86. 48 indexed citations
3.
Aoyama, Toshifumi, et al.. (1992). Monoclonal antibodies to rat liver microsomal cytochrome b5. Biochemical Pharmacology. 43(10). 2201–2208. 6 indexed citations
4.
Waxman, David J., Scott S. Sundseth, P. K. Srivastava, & D P Lapenson. (1992). Gene-specific oligonucleotide probes for alpha, mu, pi, and microsomal rat glutathione S-transferases: analysis of liver transferase expression and its modulation by hepatic enzyme inducers and platinum anticancer drugs.. PubMed. 52(20). 5797–802. 35 indexed citations
5.
Waxman, David J., D P Lapenson, Toshifumi Aoyama, et al.. (1991). Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Archives of Biochemistry and Biophysics. 290(1). 160–166. 286 indexed citations
6.
Waxman, David J., D P Lapenson, Kiyoshi Nagata, & Hugh D. Conlon. (1990). Participation of two structurally related enzymes in rat hepatic microsomal androstenedione 7α-hydroxylation. Biochemical Journal. 265(1). 187–194. 23 indexed citations
7.
Shapiro, Bernard H., James N. MacLeod, Nisar A. Pampori, et al.. (1989). Signalling Elements in the Ultradian Rhythm of Circulating Growth Hormone Regulating Expression of Sex-Dependent Forms of Hepatic Cytochrome P450*. Endocrinology. 125(6). 2935–2943. 55 indexed citations
8.
Park, Sang S., David J. Waxman, D P Lapenson, John B. Schenkman, & Harry V. Gelboin. (1989). Monoclonal antibodies to rat liver cytochrome P-450 2c/RLM5 that regiospecifically inhibit steroid metabolism. Biochemical Pharmacology. 38(18). 3067–3074. 33 indexed citations
9.
Aoyama, Toshifumi, Saki Yamano, David J. Waxman, et al.. (1989). Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human Liver. Journal of Biological Chemistry. 264(18). 10388–10395. 434 indexed citations breakdown →
10.
Waxman, David J., D P Lapenson, Joseph J. Morrissey, et al.. (1989). Androgen hydroxylation catalysed by a cell line (SD1) that stably expresses rat hepatic cytochrome P-450 PB-4 (IIB1). Biochemical Journal. 260(1). 81–85. 10 indexed citations
11.
Aoyama, Toshifumi, Ken Korzekwa, Kiyoshi Nagata, et al.. (1989). Sequence requirements for cytochrome P-450IIB1 catalytic activity. Journal of Biological Chemistry. 264(35). 21327–21333. 74 indexed citations
12.
Waxman, David J., C Attisano, F. Peter Guengerich, & D P Lapenson. (1988). Human liver microsomal steroid metabolism: Identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P-450 enzyme. Archives of Biochemistry and Biophysics. 263(2). 424–436. 382 indexed citations
13.
Waxman, David J., et al.. (1988). Antibodies to liver/kidney microsome1 in chronic active hepatitis recognize specific forms of hepatic cytochrome P-450. Gastroenterology. 95(5). 1326–1331. 31 indexed citations
15.
Waxman, David J., Gerald A. LeBlanc, Joseph J. Morrissey, Jane Staunton, & D P Lapenson. (1988). Adult male-specific and neonatally programmed rat hepatic P-450 forms RLM2 and 2a are not dependent on pulsatile plasma growth hormone for expression.. Journal of Biological Chemistry. 263(23). 11396–11406. 119 indexed citations
17.
Lapenson, D P, et al.. (1985). E receptor-related immunosuppressive factor in malignant pleural fluid and plasma: molecular mechanism of action on DNA-polymerase-alpha.. The Journal of Immunology. 135(1). 355–361. 5 indexed citations
18.
Oh, Se‐Kyung, D P Lapenson, & Adrienne Morgan. (1985). Quantification of Soluble E‐Receptor in the Serum of Patients with Various Diseases and Its Accompanying in Vitro Immunosuppression in Neoplasia. Scandinavian Journal of Immunology. 22(1). 51–60. 8 indexed citations
19.
Lapenson, D P & William C. Deal. (1979). Novel pronounced reversible inhibition of phosphofructokinase, glucose 6-phosphate dehydrogenase, and phosphoglucose isomerase by hexacyanoferrate (II). Archives of Biochemistry and Biophysics. 193(2). 521–528. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026